Qualitative Study on Factors Impeding Physical Activity During the Post-discharge Period After Hematopoietic Stem Cell Transplantation in Children

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT06099899

Collaborator

(none)

Enrollment

14.1

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

The purpose is to gain a deep understanding of the hindering factors in physical activities during the home period after pediatric hematopoietic stem cell transplantation, in order to provide references for developing targeted intervention measures.

Condition or Disease	Intervention/Treatment	Phase
Physical Activities	Other: interview

Detailed Description

From October 2023 to September 2024, a purposive sampling method will be used to select 10 post-pediatric hematopoietic stem cell transplant patients and 10 family members receiving treatment at Sun Yat-sen Memorial Hospital, Zhongshan University, as the subjects for the study. The phenomenological approach in qualitative research will be employed to conduct in-depth interviews with them, and data analysis will be performed using the Colaizzi analysis method.

Study Design

Study Type:

Observational

Anticipated Enrollment :

20 participants

Observational Model:

Family-Based

Time Perspective:

Cross-Sectional

Official Title:

Qualitative Study on Factors Impeding Physical Activity During the Post-discharge Period After Hematopoietic Stem Cell Transplantation in Children

Anticipated Study Start Date :

Oct 30, 2023

Anticipated Primary Completion Date :

Oct 30, 2024

Anticipated Study Completion Date :

Dec 31, 2024

Arms and Interventions

Arm	Intervention/Treatment
child The child's age ranges from 8 to 18 years old. They have undergone hematopoietic stem cell transplantation for at least one month. They do not have any mental disorders or consciousness impairments. The child is capable of independent walking. The interviewees are able to express their thoughts clearly.	Other: interview conduct in-depth interviews
parent The primary caregivers during the home care period for these children.	Other: interview conduct in-depth interviews

Arm

Intervention/Treatment

child

The child's age ranges from 8 to 18 years old. They have undergone hematopoietic stem cell transplantation for at least one month. They do not have any mental disorders or consciousness impairments. The child is capable of independent walking. The interviewees are able to express their thoughts clearly.

Other: interview

conduct in-depth interviews

parent

The primary caregivers during the home care period for these children.

Other: interview

conduct in-depth interviews

Outcome Measures

Primary Outcome Measures

the hindering factors in physical activities interview [2 month]
Colaizzi analysis method

Eligibility Criteria

Criteria

Ages Eligible for Study:

8 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

The child's age ranges from 8 to 18 years old.
They have undergone hematopoietic stem cell transplantation for at least one month.
They do not have any mental disorders or consciousness impairments.
The child is capable of independent walking.
The interviewees are able to express their thoughts clearly.
Both the child and their family members are informed about and have given consent to participate in this study.

Exclusion Criteria:

Relapse or the presence of other tumors
Physical activity prohibitions, such as movement disorders, platelet count <20×10⁹, -acute bleeding, hemoglobin level <80g/L
Fever with a temperature of 38.8℃ or higher due to infection
Pain score of 4 or higher
Other severe complications, such as heart failure or severe malnutrition.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Investigators

Principal Investigator: QIAN HAO, nurse, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

ClinicalTrials.gov Identifier:

NCT06099899

Other Study ID Numbers:

SYSKY-2023-972-01

First Posted:

Oct 25, 2023

Last Update Posted:

Oct 25, 2023

Last Verified:

Oct 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

hematopoietic stem cell transplantation

Study Results

No Results Posted as of Oct 25, 2023